Key facts
- This page summarizes Jason B. Daly's Form 4 filing for Amneal Pharmaceuticals, Inc. (AMRX).
- 15 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2026, 16:32.
Jason B. Daly - 03 Mar 2026 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)
- Reporting relationship
- EVP, Chief Legal Officer
- Issuer ticker
- AMRX
- Reported as of
- 03 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2026, 16:32:25 UTC
- Prior SEC filing
- 03 Mar 2026
- Next SEC filing
- 13 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Denis Butkovic, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jason B. Daly filed Form 4 for Amneal Pharmaceuticals, Inc. (AMRX) on 05 Mar 2026.
Change
- Previous filing in this sequence was filed on 03 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001906486
Primary reporting owner
Daly Jason B.
- Relationship
- EVP, Chief Legal Officer
- Address
- C/O AMNEAL PHARMACEUTICALS, INC., 400 CROSSING BOULEVARD, BRIDGEWATER
- Signature
- /s/ Denis Butkovic, Attorney-in-Fact
- Signature date
- 05 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMRX
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +22,645
- Change %
- +214%
- Price
- Shares after
- 33,251
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F2
AMRX
transaction
Class A Common Stock
Tax liability
- Transaction value
- Shares
- -10,147
- Change %
- -31%
- Price
- $13.31*
- Shares after
- 23,104
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F3
AMRX
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +38,226
- Change %
- +165%
- Price
- Shares after
- 61,330
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F2
AMRX
transaction
Class A Common Stock
Tax liability
- Transaction value
- Shares
- -16,598
- Change %
- -27%
- Price
- $13.31*
- Shares after
- 44,732
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F3
AMRX
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +24,258
- Change %
- +54%
- Price
- Shares after
- 68,990
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F2
AMRX
transaction
Class A Common Stock
Tax liability
- Transaction value
- Shares
- -10,533
- Change %
- -15%
- Price
- $13.31*
- Shares after
- 58,457
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F3
AMRX
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +305,810
- Change %
- +523%
- Price
- Shares after
- 364,267
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F4
AMRX
transaction
Class A Common Stock
Tax liability
- Transaction value
- Shares
- -132,783
- Change %
- -36%
- Price
- $13.31*
- Shares after
- 231,484
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F5
AMRX
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +35,880
- Change %
- +15%
- Price
- Shares after
- 267,364
- Date
- 04 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F2
AMRX
transaction
Class A Common Stock
Tax liability
- Transaction value
- Shares
- -15,580
- Change %
- -5.8%
- Price
- $13.30*
- Shares after
- 251,784
- Date
- 04 Mar 2026
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AMRX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -22,645
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 03 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 22,645
- Exercise price
- Footnotes
- F2, F6
AMRX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -38,226
- Change %
- -50%
- Price
- $0.000000*
- Shares after
- 38,227
- Date
- 03 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 38,226
- Exercise price
- Footnotes
- F2, F7
AMRX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -24,258
- Change %
- -25%
- Price
- $0.000000*
- Shares after
- 72,774
- Date
- 03 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 24,258
- Exercise price
- Footnotes
- F2, F8
AMRX
transaction
Derivative
Performance-Based Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -305,810
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 03 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 305,810
- Exercise price
- Footnotes
- F4
AMRX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -35,880
- Change %
- -33%
- Price
- $0.000000*
- Shares after
- 71,760
- Date
- 04 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 35,880
- Exercise price
- Footnotes
- F2, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Footnote F3
Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
Footnote F4
Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5.
Footnote F5
Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units.
Footnote F6
On March 3, 2022, the reporting person was granted 90,580 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
Footnote F7
On March 3, 2023, the reporting person was granted 152,905 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
Footnote F8
On March 3, 2025, the reporting person was granted 97,032 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
Footnote F9
On March 4, 2024, the reporting person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.